InvestorsHub Logo
Followers 34
Posts 2476
Boards Moderated 0
Alias Born 02/04/2013

Re: None

Thursday, 02/08/2024 5:55:35 PM

Thursday, February 08, 2024 5:55:35 PM

Post# of 459713
Good evening everyone. Quick question for the crowd. If we had our top line Alzheimer’s data in December of 2022 the company has had 14 months to move the ball forward. Can someone please explain to us how we have ( as far as we know ) no progress. Has the FDA guided us to do something else that hasn’t been made public? Ie complete the ole for 1 year and if everything goes well then you can submit the NDA. I find it hard to believe that the company has not had meaningful conversations with them. Or are they really just waiting for the peer review then go to the FDA? I find that hard to believe as well. Why do they need the peer review to get the go ahead for an NDA. Something is weird or did I miss or forget something. Thanks.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News